References:
1. Richesson RL, Smith SB, Malloy J, Krischer JP. Achieving standardized
medication data in clinical research studies: two approaches and
applications for implementing RxNorm. Journal of medical systems.
Springer; 2010;34:651–7.
2. What is the Phenotype KnowledgeBase? | PheKB [Internet].
[cited 2022 Apr 26]. Available from: https://phekb.org/
3. SEER*Rx - Cancer Registrar’s Interactive Antineoplastic Drugs
Database - SEER Tools [Internet]. SEER. [cited 2022 Apr 26].
Available from: https://seer.cancer.gov/tools/seerrx/index.html
4. Warner MD MS. HemOnc CC BY subset [Internet]. Harvard Dataverse;
2022 [cited 2022 Apr 26]. Available from:
https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/9CY9C6
5. Warner MD MS. HemOnc ontology [Internet]. Harvard Dataverse; 2022
[cited 2022 Apr 26]. Available from:
https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/FPO4HB
6. Wang SV, Pinheiro S, Hua W, Arlett P, Uyama Y, Berlin JA, et al.
STaRT-RWE: structured template for planning and reporting on the
implementation of real world evidence studies. bmj. British Medical
Journal Publishing Group; 2021;372.
7. Berger ML, Sox H, Willke RJ, Brixner DL, Eichler H-G, Goettsch W, et
al. Good practices for real‐world data studies of treatment and/or
comparative effectiveness: recommendations from the joint ISPOR‐ISPE
Special Task Force on real‐world evidence in health care decision
making. Value in Health. Elsevier; 2017;20:1003–8.
8. Langan SM, Schmidt SA, Wing K, Ehrenstein V, Nicholls SG, Filion KB,
et al. The reporting of studies conducted using observational routinely
collected health data statement for pharmacoepidemiology (RECORD-PE).
bmj. British Medical Journal Publishing Group; 2018;363.
9. Blake KV, Smeraldi C, Kurz X, Arlett P, Blackburn S, Fitt H. The
European Network of Centres for Pharmacoepidemiology and
Pharmacovigilance: application to diabetes and vascular disease. The
British Journal of Diabetes & Vascular Disease. Sage Publications Sage
UK: London, England; 2011;11:304–7.